Mortality rates are increased in acromegaly. Previous studies have shown that growth hormone and insulin-like growth factor 1 levels, male gender, age, hypertension, delayed diagnosis and prior pituitary radiotherapy are independent predictors of increased mortality. A new study by Sherlock et al. now adds adrenal insufficiency and hydrocortisone replacement dose to the list of independent predictors of acromegaly-associated mortality.